Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early stage HER2-positive breast cancer
Findings from a large phase III study, ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation), suggest…
Browsing: ASCO 2014
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Key candidate genes and pathways in the biogenesis of gastric cancer
- Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery
- An international journey to save her life fuels Ana’s advocacy
- Component of keto diet plus immunotherapy may reduce prostate cancer
- Regulating cholesterol levels might be the key to improving cancer treatment
- Resource-appropriate cancer care, including coexisting health issues of HIV and cancer, to be addressed during meeting in Nairobi
- Microbiome researchers challenge the state of the art in colon cancer biomarker discovery
- Researchers examine implementation of psychosocial support program for adolescents with cancer